Armata Pharmaceuticals, Inc. Common Stock (ARMP)

CapEx to Revenue

0.68%

Quarterly · Period ending:

ARMP logo

ARMP CapEx to Revenue

Latest reported0.68%
ARMP Quarterly CapEx/Revenue (0.00% → 0.68%)
High-resolution chart · PNG

ARMP capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Armata Pharmaceuticals, Inc. Common Stock CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
33.3333%
100%
12.5%
33.3333%
100%
13.3333%
37.5%
500%
250%
0%
600%
200%
300%
300%
150%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.